/PRNewswire/ iTolerance, Inc., an early-stage regenerative medicine company developing technology to enable tissue, organoid or cell therapy without the.
Findings are expected to inform portfolio company's innovative approach to Regenerative Medicine Morphoceuticals Inc., a portfolio company of Juvenescence Ltd., hailed the results of a long-term study
Morphoceuticals Inc., a portfolio company of Juvenescence Ltd., hailed the results of a long-term study published by its founders in Science Advances showing the successful regeneration of limbs in Xenopus laevis (African clawed frog).
/PRNewswire/ Morphoceuticals Inc. hailed the results of a long-term study published by its founders in Science Advances showing the successful regeneration.